Actively Recruiting
Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
Led by Immanuel Kant Baltic Federal University · Updated on 2023-09-22
1200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
I
Immanuel Kant Baltic Federal University
Lead Sponsor
C
Center of Endourology "Endocenter"
Collaborating Sponsor
AI-Summary
What this Trial Is About
The study attempts to quantify the relative risks for mortality, anastomotic leakage and other early and late postoperative complications, recurrence rate, cancer-specific survival, recurrence-free survival after colorectal surgery for patients with colorectal cancer depending on the localization of the tumor.
CONDITIONS
Official Title
Factors Affecting the Results of Treatment of Patients With Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Histologically proven primary adenocarcinoma of bowel
- Indications for surgical treatment of colorectal cancer based on oncological council decision
- Signed informed consent agreeing to attend all study visits
You will not qualify if you...
- Unresectable tumor or contraindications to surgery
- Indications for chemotherapy or radiation therapy before surgery
- Patient withdrawal from the trial or loss of follow-up
- Emergent operation
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Baltic Federal University
Kaliningrad, Kaliningrad Oblast, Russia, 236041
Actively Recruiting
Research Team
T
Tatiana N Garmanova, PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here